3695 — GMO Research & AI Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥4bn
- ¥4bn
- ¥5bn
- 97
- 65
- 24
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 201 | 240 | 385 | 458 | 428 |
Depreciation | |||||
Non-Cash Items | 2.68 | 12.8 | 49.3 | -16.3 | -75 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -143 | 39.4 | -21.1 | -396 | 32.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 148 | 363 | 482 | 132 | 475 |
Capital Expenditures | -70.6 | -95 | -75.2 | -91.8 | -121 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -111 | -0.078 | 24.6 | -19.5 | -10.5 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -182 | -95 | -50.7 | -111 | -131 |
Financing Cash Flow Items | -0.001 | — | — | -0.001 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -134 | -82.6 | -96.5 | -145 | -187 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -164 | 186 | 352 | -97.9 | 168 |